Why I Bought The Manufacturing Before The Marketing

By Kemal Whyte, founder and CEO of Rebel X Brands.

Last updated: July 2026

The least glamorous decision I ever made was buying an extract line. No launch post. No press. Just a lease, a room that smelled like solvent, and a number on a contract that I did not enjoy signing.

Everyone told me it was the wrong order. Build the brand first. Get demand. Let somebody else handle production, because manufacturing is capital-heavy and slow and boring, and the money is in marketing. That is the standard advice and it is not stupid advice. It is just advice written for a different industry than the one I am in.

Here is why I went the other way, and what it actually cost.

The problem with renting your product

When you white label, you do not own a product. You own a purchase order.

What you do not get to outsource is the liability. The FDA is unusually blunt about this. In its compliance guide to the dietary supplement cGMP rule, it states that a firm which contracts out its manufacturing is still ultimately responsible for the product it releases for distribution, and has an obligation to know what is being done and how. Read that again. The rules already assume you are answerable for a process you may have no visibility into.

That distinction feels academic right up until the day it is not. Your contract manufacturer changes a supplier without telling you, because their contract is with their supplier, not with you. Your alkaloid content drifts between batches and you find out from a customer, not from a lab report. A bigger client shows up and suddenly your run gets scheduled behind theirs. Or they raise your price twelve percent and your options are pay it or start over.

None of that is because contract manufacturers are villains. It is because their incentives are theirs and yours are yours, and when those two things separate, you are the one holding a brand and no way to make it.

In an industry where the product is a plant, the variance is real, and the regulation is moving, that gap is not a business risk. It is the whole business.

What owning it actually changed

Four things, and only one of them is the one people expect.

I can test whatever I want, whenever I want. Not the tests the contract manufacturer includes. Not the certificate they hand me at the end. I can pull from a batch mid-run and send it out, and if it comes back wrong I can stop the run instead of finding out after it is in bottles with my name on them. Every claim I make about testing is a claim I can stand behind, because I control the thing being tested. If you want to know what those claims should look like from the buying side, I wrote a whole piece on how to read a certificate of analysis.

I can say no to a formula. This one matters more than people think. When the concentrate boom hit and everybody wanted the strongest possible thing on the shelf, I could decline to make it. Not negotiate. Decline. If I had been renting capacity, the pressure to keep the line busy would have made that a much harder conversation with myself.

I found out what things actually cost. Owning production means you see every input, and once you see them you cannot unsee the markup you were paying. That changed how I priced, what I stocked, and which products I quietly killed because the math never worked and I had been hiding it from myself inside a blended cost per unit.

The regulation stopped being a threat. This is the one nobody predicts. When a state tightens its rules, the operators who panic are the ones who cannot change their product. I can reformulate, re-test, and re-label without asking permission from a partner whose priority is their biggest account. The same goes for voluntary standards: the American Kratom Association's GMP Standards Program puts an independent auditor inside your facility on a recurring basis, which is a much shorter conversation when the facility is yours. Rules that scare the industry are rules I can meet, and meeting them removes competitors who cannot.

What it cost, honestly

I am not going to sell you the version where this was free.

It ate the money that would have been marketing budget for about two years. Two years of watching better-funded brands buy attention I could not afford to buy back. Some of them are gone now, and some of them are much bigger than me, and I do not pretend the outcome was guaranteed.

It made me an operator before it made me a marketer. I learned equipment, batch records, and staffing at the exact age most founders are learning growth channels. There are skills I am years behind on because of it. And the standard you are learning to hit is not a vibe, it is 21 CFR Part 111, sixteen subparts covering personnel, facilities, equipment, component controls, records and complaint handling. Nobody warns you how much of running a plant is paperwork.

And it is a fixed cost that does not care how your month went. A slow quarter with a contract manufacturer is a smaller order. A slow quarter with your own line is rent, payroll, and a room full of equipment that still has to be paid for. That pressure is real and it does not go away.

Who this is actually for

Not everyone. If your product is stable, commoditised, and unregulated, rent your production and put every dollar into demand. That is the right call and I would make it too.

Buy the manufacturing when three things are true at once. The product varies batch to batch in ways a customer can feel. The regulation is live and moving. And your entire brand promise is that you are the honest one.

That third condition is the one people skip. You cannot build a brand on transparency and outsource the part you are being transparent about. Sooner or later somebody asks a question that only the manufacturer can answer, and if that is not you, you are guessing in public.

The version I would tell a younger me

Marketing compounds faster. Manufacturing compounds harder.

Marketing you can restart. You can change the name, change the channel, run it again with what you learned. Manufacturing is slower to build and much slower to lose, and when the market turns hostile, it is the thing still standing.

I did not know that when I signed the lease. I would like to claim I did. What I actually had was a suspicion that in an industry this young and this contested, the people who owned the physical thing would still be here when the people who owned the audience had moved on to the next category.

That part turned out to be right.

If you are working through this decision yourself, the FACTORY playbook goes deeper into the numbers than I can here. It is free, along with nine others, on the industry intel page.

Disclaimer: This article is one operator's experience and general commentary. It is not legal, financial, or investment advice. Nothing here is a health claim, and statements about botanical products have not been evaluated by the Food and Drug Administration.

Written by Kemal Whyte, founder and CEO of Rebel X Brands, Austin, Texas.